# Analog Devices Inc: Form 10-Q for the period ended May 2, 2026

- Company: [Analog Devices Inc](/companies/adi.md) (CIK 6281)
- Form: 10-Q
- Filed: 2026-05-20
- Accepted by EDGAR: May 20, 2026, 07:04 ET
- Period: 2026-05-02
- Accession: 0000006281-26-000052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/6281/000000628126000052/adi-20260502.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/6281/000000628126000052/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-05-02.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-02-01 to 2026-05-02 | $3.62bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2025-11-02 to 2026-05-02 | $6.78bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-02-01 to 2026-05-02 | $1.18bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2025-11-02 to 2026-05-02 | $2.30bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2026-02-01 to 2026-05-02 | $2.44bn | us-gaap:GrossProfit |
| Gross profit | 6 months, 2025-11-02 to 2026-05-02 | $4.48bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2026-02-01 to 2026-05-02 | $509.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2025-11-02 to 2026-05-02 | $976.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2026-02-01 to 2026-05-02 | $362.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2025-11-02 to 2026-05-02 | $708.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2026-02-01 to 2026-05-02 | $1.38bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2025-11-02 to 2026-05-02 | $2.38bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2026-02-01 to 2026-05-02 | $87.6m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2025-11-02 to 2026-05-02 | $174.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2026-02-01 to 2026-05-02 | $148.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2025-11-02 to 2026-05-02 | $263.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-02-01 to 2026-05-02 | $1.18bn | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2025-11-02 to 2026-05-02 | $2.01bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-02-01 to 2026-05-02 | $2.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2025-11-02 to 2026-05-02 | $4.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-02-01 to 2026-05-02 | $2.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2025-11-02 to 2026-05-02 | $4.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-02-01 to 2026-05-02 | 490,458,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2025-11-02 to 2026-05-02 | 491,057,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2025-11-02 to 2026-05-02 | $2.24bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2025-11-02 to 2026-05-02 | $247.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2025-11-02 to 2026-05-02 | $1.02bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2025-11-02 to 2026-05-02 | $1.29bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-05-02 | $2.44bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-05-02 | $7.81bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-05-02 | $47.95bn | us-gaap:Assets |
| Current liabilities | at 2026-05-02 | $4.46bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2026-05-02 | $7.24bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2026-05-02 | $899.2m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2026-05-02 | $550.2m | us-gaap:CommercialPaper |
| Shareholders' equity | at 2026-05-02 | $33.74bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2026-05-02 | 487,087,040 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 23,797 characters.

This information should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended November 1, 2025 (fiscal 2025).

This Quarterly Report on Form 10-Q, including the following discussion, contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on current expectations, estimates, forecasts and projections about the industries in which we operate and the beliefs and assumptions of our management. Words such as “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “continues,” “potential,” “may,” “could” and “will,” and variations of such words and similar expressions are intended to identify such forward-looking statements, however, the absence of the foregoing words or expressions does not mean that a statement is not forward-looking. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors.

The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in the forward-looking statements: economic, political, legal and regulatory uncertainty or conflicts; recently announced and future tariffs and other trade restrictions; changes in export classifications, import and export regulations or duties and tariffs; changes in demand for semiconductor products; performance of independent distributors; manufacturing delays, product and raw materials availability and supply chain disruptions; products may be diverted from our authorized distribution channels; our development of technologies and research and development investments; our ability to compete successfully in the markets in which we operate; our future liquidity, capital needs and capital expenditures; our ability to recruit and retain key personnel; risks related to acquisitions or other strategic transactions; unanticipated difficulties or expenditures relating to integrating acquired businesses; security breaches or other cyber incidents; risks related to the use of artificial intelligence in our business operations, products and services; adverse results in litigation; the outcome of any regulatory actions, including governmental inquiries, investigations or enforcement proceedings in the event of noncompliance or alleged noncompliance with laws or regulations; reputational damage; changes in our estimates of our expected tax rates based on current tax law; risks related to our indebtedness; the discretion of our Board of Directors to declare dividends and our ability to pay dividends in the future; factors impacting our ability to repurchase shares; and uncertainty as to the long-term value of our common stock. Additional factors that could cause actual results to differ materially from those described in these forward-looking statements include the risk factors included in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for fiscal 2025. Forward-looking statements represent management’s current expectations and are inherently uncertain. We undertake no obligation to revise or update any forward-looking statements, including to reflect events or circumstances occurring after the date of the filing of this report, except to the extent required by law.

### Results of Operations

#### Overview

Amounts in the tables below are reflected in thousands except per share amounts and percentages.

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $3,623,465 | $2,640,068 | $983,397 | 37% |
| Gross margin % | 67.3% | 61.0% |  |  |
| Net income | $1,176,350 | $569,770 | $606,580 | 106% |
| Net income as a % of revenue | 32.5% | 21.6% |  |  |
| Diluted EPS | $2.40 | $1.14 | $1.26 | 111% |
|  | **Six Months Ended** |  |  |  |
|  | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| Revenue | $6,783,728 | $5,063,242 | $1,720,486 | 34% |
| Gross margin % | 66.1% | 60.1% |  |  |
| Net income | $2,007,176 | $961,086 | $1,046,090 | 109% |
| Net income as a % of revenue | 29.6% | 19.0% |  |  |
| Diluted EPS | $4.09 | $1.93 | $2.16 | 112% |

#### Revenue Trends by End Market

The following tables summarize revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which our product will be incorporated. The assignment of products to end markets may change over time. When this occurs, we reclassify revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market.

|  | Three Months Ended May 2, 2026 Revenue % of Revenue\* Y/Y% | May 3, 2025 Revenue % of Revenue\* |
| --- | ---: | ---: |
| Industrial | $1,799,413 50% 56% | $1,150,315 44% |
| Automotive | 871,565 24% 2% | 856,090 32% |
| Communications | 554,728 15% 79% | 310,604 12% |
| Consumer | 397,759 11% 23% | 323,059 12% |
| Total revenue | $3,623,465 100% 37% | $2,640,068 100% |
|  | **Six Months Ended** |  |
|  | **May 2, 2026** | **May 3, 2025** |
|  | **Revenue** **% of Revenue\*** **Y/Y%** | **Revenue** **% of Revenue\*** |
| Industrial | $3,296,449 49% 48% | $2,220,569 44% |
| Automotive | 1,681,709 25% 5% | 1,596,349 32% |
| Communications | 1,009,911 15% 65% | 610,905 12% |
| Consumer | 795,659 12% 25% | 635,419 13% |
| Total revenue | $6,783,728 100% 34% | $5,063,242 100% |
| \* The sum of the individual percentages may not equal the total due to rounding. |  |  |

Revenue increased 37% and 34% in the three- and six-month periods ended May 2, 2026 as compared to the same periods of the prior fiscal year as a result of a broad-based increase in demand for our products, notably within all Industrial sub-markets with the highest growth coming from our test equipment and aerospace and defense sub-markets. Revenue also increased in the data center portion of the Communications end market related to artificial intelligence-driven infrastructure investments.

#### Revenue by Sales Channel

The following tables summarize revenue by sales channel. We sell our products globally through a direct sales force, third-party distributors, independent sales representatives and via our website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers. Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.

| Channel | Three Months Ended May 2, 2026 Revenue % of Revenue\* | May 3, 2025 Revenue % of Revenue\* |
| --- | ---: | ---: |
| Distributors | $2,071,312 57% | $1,480,088 56% |
| Direct customers | 1,520,090 42% | 1,125,775 43% |
| Other | 32,063 1% | 34,205 1% |
| Total revenue | $3,623,465 100% | $2,640,068 100% |
|  | **Six Months Ended** |  |
|  | **May 2, 2026** | **May 3, 2025** |
|  | **Revenue** **% of Revenue\*** | **Revenue** **% of Revenue\*** |
| Channel |  |  |
| Distributors | $3,813,606 56% | $2,855,552 56% |
| Direct customers | 2,897,220 43% | 2,145,647 42% |
| Other | 72,902 1% | 62,043 1% |
| Total revenue | $6,783,728 100% | $5,063,242 100% |
| \* The sum of the individual percentages may not equal the total due to rounding. |  |  |

As indicated in the tables above, the percentage of total revenue sold via each channel has remained relatively consistent in the periods presented, but can fluctuate from time to time based on end market revenue trends.

#### Gross Margin

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change | Six Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross margin | $2,439,798 | $1,611,610 | $828,188 | 51% | $4,484,773 | $3,041,913 | $1,442,860 | 47% |
| Gross margin % | 67.3% | 61.0% |  |  | 66.1% | 60.1% |  |  |

Gross margin percentage increased by 630 and 600 basis points in the three- and six-month periods ended May 2, 2026 as compared to the same periods of the prior fiscal year, primarily due to higher utilization of our manufacturing fixed costs as a result of increased customer demand and favorable mix of products sold into our end markets.

#### Research and Development (R&D)

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change | Six Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| R&D expenses | $509,323 | $441,837 | $67,486 | 15% | $976,723 | $844,729 | $131,994 | 16% |
| R&D expenses as a % of revenue | 14% | 17% |  |  | 14% | 17% |  |  |

17

R&D expenses increased in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, primarily as a result of higher R&D employee-related variable compensation expenses. R&D expenses declined as a percentage of revenue, primarily reflecting higher revenue levels and improved operating leverage. We expect to continue the development of innovative technologies and processes for new products, which we view as critical to our future growth. We believe that a continued commitment to R&D is essential to maintain product leadership with our existing products as well as to provide innovative new product offerings.

#### Selling, Marketing, General and Administrative (SMG&A)

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change | Six Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| SMG&A expenses | $362,810 | $302,669 | $60,141 | 20% | $708,063 | $587,465 | $120,598 | 21% |
| SMG&A expenses as a % of revenue | 10% | 11% |  |  | 10% | 12% |  |  |

SMG&A expenses increased in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, primarily as a result of higher SMG&A employee-related variable compensation expenses and higher salary and benefit expenses. SMG&A expenses declined as a percentage of revenue, primarily reflecting higher revenue levels and improved operating leverage.

#### Special Charges, Net

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change | Six Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Special charges, net | $— | $1,745 | $(1,745) | (100)% | $47,982 | $65,632 | $(17,650) | (27)% |

Special charges, net decreased in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, primarily due to decreased charges related to our Global Repositioning Actions. The decrease in the six-month period was partially offset by a $15.6 million impairment charge recorded in the first quarter of fiscal 2026 related to the asset group in our leased facilities in San Jose, California.

#### Provision for Income Taxes

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | Six Months Ended May 2, 2026 | May 3, 2025 | $ Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Provision for income taxes | $148,478 | $56,158 | $92,320 | $263,523 | $100,418 | $163,105 |
| Effective income tax rate | 11.2% | 9.0% |  | 11.6% | 9.5% |  |

The primary driver for our increased tax rate in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, is the increase in taxes paid on our international profits. This results in higher non-deductible foreign tax expense under the global intangible low-taxed income (GILTI) regime, which has the effect of increasing our effective tax rate.

#### Net Income

|  | Three Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change | Six Months Ended May 2, 2026 | May 3, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $1,176,350 | $569,770 | $606,580 | 106% | $2,007,176 | $961,086 | $1,046,090 | 109% |
| Net income as a % of revenue | 32.5% | 21.6% |  |  | 29.6% | 19.0% |  |  |
| Diluted EPS | $2.40 | $1.14 |  |  | $4.09 | $1.93 |  |  |

Net income increased in the three-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, as the result of a $701.7 million increase in operating income, partially offset by a $92.3 million increase in provision for income taxes.

Net income increased in the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, as the result of a $1,207.4 million increase in operating income, partially offset by a $163.1 million increase in provision for income taxes.

### Liquidity and Capital Resources

At May 2, 2026, our principal source of liquidity was $3.4 billion of cash, cash equivalents and short-term investments, of which approximately $2.2 billion was held in the United States, and the balance of which was held outside the United States in various foreign subsidiaries. We manage our worldwide cash requirements by, among other things, reviewing available funds held by our foreign subsidiaries and the cost effectiveness by which those funds can be accessed in the United States. We do not expect current regulatory restrictions or taxes on repatriation to have a material adverse effect on our overall liquidity, financial condition or results of operations. Our cash, cash equivalents and short-term investments consist of highly liquid investments, including money market funds and corporate and bank obligations. We maintain these balances with counterparties with high credit ratings, and continually monitor the amount of credit exposure to any one issuer and diversify our investments in order to minimize our credit risk.

We believe that our existing sources of liquidity and cash expected to be generated from future operations, together with existing and anticipated available short- and long-term financing, will be sufficient to fund operations, capital expenditures, acquisitions, research and development efforts and dividend payments in the immediate future and for at least the next twelve months.

|  | Six Months Ended May 2, 2026 | May 3, 2025 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $2,240,556 | $1,946,287 |
| Net cash provided by operations as a % of revenue | 33% | 38% |
| Net cash (used for) provided by investing activities | $(158,955) | $133,892 |
| Net cash used for financing activities | $(2,144,091) | $(1,695,286) |

The following changes contributed to the net change in cash and cash equivalents in the six-month period ended May 2, 2026 as compared to the same period in fiscal 2025.

#### Operating Activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in operating assets and liabilities. The increase in cash provided by operating activities during the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, was mainly the result of higher net income adjusted for non-cash items.

#### Investing Activities

Investing cash flows generally consist of purchases and sales of property, plant and equipment, purchases, sales and maturities of available-for-sale investments; and acquisitions of other businesses. The change in investing cash flows during the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, was primarily the result of a decrease in maturities of our available-for-sale investments. The change in investing cash flows also included the sale of property, plant and equipment during fiscal 2025.

#### Financing Activities

Financing cash flows generally consist of payments of dividends to stockholders, repurchases of common stock, issuances and repayments of debt and proceeds from the sale of shares of common stock pursuant to employee equity incentive plans. The change in cash used for financing activities during the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, was primarily the result of higher common stock repurchases partially offset by debt repayments during fiscal 2025.

#### Working Capital

|  | May 2, 2026 | November 1, 2025 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Accounts receivable | $2,051,733 | $1,436,075 | $615,658 | 43% |
| Days sales outstanding\* | 43 | 44 |  |  |
| Inventory | $1,848,405 | $1,656,323 | $192,082 | 12% |
| Days cost of sales in inventory\* | 139 | 130 |  |  |

\* We use the average of the current quarter and prior quarter ending net accounts receivable and ending inventory balance in our calculation of days sales outstanding and days cost of sales in inventory, respectively.

The increase in accounts receivable in dollars was primarily the result of increased sales levels and variations in the timing of collections and billings.

Inventory increased primarily as a result of building inventory levels to support increased demand.

Current liabilities increased to $4.5 billion at May 2, 2026 as compared to $3.2 billion at the end of fiscal 2025 primarily due to the reclassification of $0.9 billion of debt due in December 2026 to current liabilities as well as an increase in accrued liabilities, partially offset by a decrease in income taxes payable.

#### Debt

As of May 2, 2026, our debt obligations consisted of the following:

|  | Principal Amount Outstanding |
| --- | ---: |
| Commercial paper notes | $550,198 |
| 2026 Notes, due December 2026 | 900,000 |
| 2027 Notes, due June 2027 | 440,212 |
| 2028 Notes, due June 2028 | 850,000 |
| 2028 Notes, due October 2028 | 750,000 |
| 2030 Notes, due June 2030 | 650,000 |
| 2031 Notes, due October 2031 | 1,000,000 |
| 2032 Notes, due October 2032 | 300,000 |
| 2034 Notes, due April 2034 | 550,000 |
| 2036 Notes, due December 2036 | 144,278 |
| 2041 Notes, due October 2041 | 750,000 |
| 2045 Notes, due December 2045 | 332,587 |
| 2051 Notes, due October 2051 | 1,000,000 |
| 2054 Notes, due April 2054 | 550,000 |
| Total debt | $8,767,275 |

The indentures governing our outstanding notes contain covenants that may limit our ability to: incur, create, assume or guarantee any debt for borrowed money secured by a lien upon a principal property; enter into sale and lease-back transactions with respect to a principal property; and consolidate with or merge into, or transfer or lease all or substantially all of our assets to, any other party. As of May 2, 2026, we were in compliance with these covenants.

Under our commercial paper program, we may issue short-term, unsecured commercial paper notes in amounts up to a maximum aggregate face amount of $3.0 billion outstanding at any time, with maturities of up to 397 days from the date of issuance. As of May 2, 2026, we had $0.6 billion of outstanding borrowings under the commercial paper program recorded in the Condensed Consolidated Balance Sheet. We intend to use the net proceeds of the commercial paper program for general corporate purposes, including without limitation, repayment of indebtedness, stock repurchases, acquisitions, capital expenditures and working capital.

#### Revolving Credit Facility

Our Fourth Amended and Restated Revolving Credit Agreement, dated as of April 11, 2025, with Bank of America N.A. as administrative agent and the other banks identified therein as lenders (the Revolving Credit Agreement) provides for a five-year unsecured revolving credit facility in an aggregate principal amount not to exceed $3.0 billion (subject to certain terms and conditions).

We may borrow under the Revolving Credit Agreement in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes. The terms of the Revolving Credit Agreement impose restrictions on our ability to undertake certain transactions, to create certain liens on assets and to incur certain subsidiary indebtedness. In addition, the Revolving Credit Agreement contains an interest coverage covenant which requires the ratio of consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) to consolidated interest charges to be greater than 3.0 to 1.0. As of May 2, 2026, we were in compliance with these covenants.

#### Stock Repurchase Program

As of May 2, 2026, our Board of Directors had authorized us to repurchase an aggregate of $26.7 billion of our common stock under our common stock repurchase program and $8.5 billion remained available for repurchases under the current authorized program. Repurchased shares are held as authorized but unissued shares of common stock. Unless terminated earlier by resolution of our Board of Directors, the repurchase program will expire when the full dollar amount of the authorization has been used to repurchase shares under the program. Future repurchases of common stock will be dependent upon our financial position, results of operations, outlook, liquidity and other factors we deem relevant.

#### Capital Expenditures

Net additions to property, plant and equipment were $247.0 million in the first six months of fiscal 2026. We expect capital expenditures for fiscal 2026 to be between approximately 4% and 6% of fiscal 2026 revenue. These capital expenditures will be funded with a combination of cash on hand and cash expected to be generated from future operations, together with existing and anticipated available short- and long-term financing.

#### Dividends

On May 19, 2026, our Board of Directors declared a cash dividend of $1.10 per outstanding share of common stock. The dividend will be paid on June 16, 2026 to all shareholders of record at the close of business on June 2, 2026 and is expected to total approximately $535.8 million. We currently expect quarterly dividends to continue in future periods, although they remain subject to determination and declaration by our Board of Directors. The payment of future dividends, if any, will be based on several factors, including our financial performance, outlook and liquidity.

### New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board that are adopted by us as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards will not have a material impact on our future financial condition, results of operations, and disclosures. See Note 11, *New Accounting Pronouncements,* in the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for a description of recently issued and adopted accounting pronouncements, including the dates of adoption and impact on our historical financial condition, results of operations, and disclosures.

## Market risk

As filed, 518 characters.

We are subject to market risks related to our financial instruments, including those identified in Part II, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk” of our Annual Report on Form 10-K for the fiscal year ended November 1, 2025, which was filed with the Securities and Exchange Commission on November 25, 2025. There were no material changes in the six-month period ended May 2, 2026 to the information identified in the Annual Report on Form 10-K for the fiscal year ended November 1, 2025.

## Controls and procedures

As filed, 2,085 characters.

(a) *Evaluation of Disclosure Controls and Procedures*. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of May 2, 2026. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of May 2, 2026, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

(b) *Changes in Internal Control over Financial Reporting.* No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended May 2, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 364 characters.

We are subject to a number of risks that could adversely affect our business, results of operations, financial condition and future prospects, including those identified in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended November 1, 2025, which was filed with the Securities and Exchange Commission on November 25, 2025.

Filed May 20, 2026.
Source: SEC EDGAR, the filing index for accession 0000006281-26-000052. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.